GLTO
Price
$2.77
Change
-$0.46 (-14.24%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
3.78M
SYRE
Price
$13.96
Change
-$1.53 (-9.88%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
933.38M
34 days until earnings call
Ad is loading...

GLTO vs SYRE

Header iconGLTO vs SYRE Comparison
Open Charts GLTO vs SYREBanner chart's image
Galecto
Price$2.77
Change-$0.46 (-14.24%)
Volume$100
Capitalization3.78M
Spyre Therapeutics
Price$13.96
Change-$1.53 (-9.88%)
Volume$17.49K
Capitalization933.38M
GLTO vs SYRE Comparison Chart
Loading...
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLTO vs. SYRE commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLTO is a Hold and SYRE is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (GLTO: $2.86 vs. SYRE: $13.96)
Brand notoriety: GLTO and SYRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLTO: 10% vs. SYRE: 147%
Market capitalization -- GLTO: $3.78M vs. SYRE: $933.38M
GLTO [@Biotechnology] is valued at $3.78M. SYRE’s [@Biotechnology] market capitalization is $933.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLTO’s FA Score shows that 1 FA rating(s) are green whileSYRE’s FA Score has 0 green FA rating(s).

  • GLTO’s FA Score: 1 green, 4 red.
  • SYRE’s FA Score: 0 green, 5 red.
According to our system of comparison, GLTO is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLTO’s TA Score shows that 2 TA indicator(s) are bullish while SYRE’s TA Score has 4 bullish TA indicator(s).

  • GLTO’s TA Score: 2 bullish, 7 bearish.
  • SYRE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SYRE is a better buy in the short-term than GLTO.

Price Growth

GLTO (@Biotechnology) experienced а -16.62% price change this week, while SYRE (@Biotechnology) price change was -21.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

GLTO is expected to report earnings on Nov 05, 2024.

SYRE is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($933M) has a higher market cap than GLTO($3.78M). GLTO YTD gains are higher at: -30.538 vs. SYRE (-40.034). GLTO has higher annual earnings (EBITDA): -19.68M vs. SYRE (-208.57M). SYRE has more cash in the bank: 603M vs. GLTO (19.7M). SYRE has less debt than GLTO: SYRE (0) vs GLTO (32K). GLTO (0) and SYRE (0) have equivalent revenues.
GLTOSYREGLTO / SYRE
Capitalization3.78M933M0%
EBITDA-19.68M-208.57M9%
Gain YTD-30.538-40.03476%
P/E RatioN/A1.72-
Revenue00-
Total Cash19.7M603M3%
Total Debt32K0-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
80
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLTOSYRE
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 7 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LEG8.300.44
+5.60%
Leggett & Platt
GLDD9.060.15
+1.68%
Great Lakes Dredge & Dock Corp
DVA154.292.38
+1.57%
DaVita
ZTEK1.13-0.02
-1.74%
Zentek Ltd
QH1.40-0.05
-3.11%
Quhuo Limited

GLTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLTO has been loosely correlated with MURA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GLTO jumps, then MURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLTO
1D Price
Change %
GLTO100%
+14.54%
MURA - GLTO
37%
Loosely correlated
+6.45%
XERS - GLTO
35%
Loosely correlated
+1.38%
SYRE - GLTO
33%
Poorly correlated
+1.27%
HUMA - GLTO
31%
Poorly correlated
-2.01%
LSB - GLTO
30%
Poorly correlated
-4.58%
More

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with BEAM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
-9.88%
BEAM - SYRE
48%
Loosely correlated
-10.93%
APGE - SYRE
47%
Loosely correlated
-7.61%
CGON - SYRE
46%
Loosely correlated
-15.74%
PRME - SYRE
46%
Loosely correlated
-10.06%
IDYA - SYRE
46%
Loosely correlated
-4.77%
More